A critical 2022 survey of Ethiopian health facilities revealed alarming deficiencies in oxytocin storage practices that directly compromise maternal safety. The data showed that only 50 percent of facilities monitored oxytocin temperature on a daily basis, while 30 percent lacked refrigerated storage entirely. These gaps are particularly concerning given that proper temperature control is essential for maintaining oxytocin’s potency in preventing postpartum haemorrhage.
These findings prompted swift action from Ethiopia’s Ministry of Health, which recognized that existing vaccine cold chain infrastructure could be leveraged to address oxytocin storage challenges. The integration initiative represents a practical solution that builds on established systems already maintained across the country’s health facility network.
The data underscores why structured policy reform—informed by local evidence and stakeholder input—is essential for improving maternal health outcomes in resource-limited contexts.
Was this article helpful?
